AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Antiprotozoal Agent: Quinacrine has historically been used as an antiprotozoal medication, particularly for the treatment of malaria caused by Plasmodium species. However, due to the development of more effective and safer antimalarial drugs, such as chloroquine and artemisinin-based combination therapies, quinacrine is rarely used for this purpose today.
Antiparasitic Agent: Quinacrine has also been used for the treatment of certain parasitic infections, including Giardia lamblia and tapeworm infections. It is sometimes employed as an alternative therapy when other medications are ineffective or unavailable.
Antirheumatic Agent: Quinacrine has been investigated for its potential role in the treatment of autoimmune diseases, particularly rheumatoid arthritis and lupus erythematosus. It is believed to exert immunomodulatory effects by inhibiting the activity of phospholipase A2 and altering lysosomal function. However, its use in rheumatic conditions has declined over time due to the availability of more effective and safer alternative treatments.
Anticancer Agent: Quinacrine has demonstrated anticancer properties in preclinical studies, including inhibition of tumor growth and induction of apoptosis (programmed cell death) in cancer cells. It has been investigated as a potential treatment for various types of cancer, including breast cancer, ovarian cancer, and leukemia. However, further research is needed to determine its efficacy and safety in clinical settings.
Antiviral Agent: Quinacrine has been studied for its antiviral activity against certain viruses, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV). It has been shown to inhibit viral replication in vitro, but its clinical utility for the treatment of viral infections remains uncertain.
Immune Modulation: Quinacrine has been investigated for its immunomodulatory effects, including its ability to suppress the production of proinflammatory cytokines and modulate immune responses. These properties may have potential applications in the treatment of autoimmune and inflammatory diseases, although more research is needed to fully understand its mechanisms of action and therapeutic potential.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]